Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease

Vedolizumab Serum Trough Concentrations and Response to Dose Escalation in Inflammatory Bowel Disease

Serum vedolizumab concentrations are associated with clinical response although, it is unknown if vedolizumab concentrations predict response to dose escalation. The aim of this study was to identify if vedolizumab trough concentrations predicted the response to vedolizumab dose escalation. We asses...

Full description

Bibliographic Details
Main Authors: Byron P. Vaughn, Andres J. Yarur, Elliot Graziano, James P. Campbell, Abhik Bhattacharya, Jennifer Y. Lee, Katherine Gheysens, Konstantinos Papamichael, Mark T. Osterman, Adam S. Cheifetz, Raymond K. Cross
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
Crohn’s disease
ulcerative colitis
therapeutic drug monitoring
Online Access:https://www.mdpi.com/2077-0383/9/10/3142

Internet

https://www.mdpi.com/2077-0383/9/10/3142

Similar Items